Dr. Azure Tariro Makadzange, MD

Dr. Makadzange practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Makadzange's NPI, 1841440716, was assigned on September 26, 2008. Dr. Makadzange graduated from Harvard Medical School in 2005. Dr. Makadzange holds California license C157375.

Dr. Makadzange's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Makadzange's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Makadzange to 1 more hospital and 1 medical group, each named with a free account. Dr. Makadzange's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Makadzange practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Makadzange's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Makadzange is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Makadzange's licenses on file in 3 states: California, Massachusetts and Washington.

CMS data shows 57 Medicare services from Dr. Makadzange across 2 procedure codes in 2024, for 33 Medicare patients. Medicare paid $4,710 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Makadzange in 2024. The largest group is 75 to 84, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Makadzange's median patient age at 48, with 73% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Makadzange for performance year 2024, reported as part of a group. Dr. Makadzange accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Makadzange, published from 2003 to 2023. 2023 was the busiest year, with 3. The most frequent topics are HIV Infections, Zimbabwe and Anti-HIV Agents. Dr. Makadzange has published most often in AIDS. Dr. Makadzange's most frequent co-author is Admire Hlupeni, MD.

CMS Open Payments shows 4 general payments to Dr. Makadzange from 2 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $124.

Dr. Makadzange graduated from Harvard Medical School in 2005.

Dr. Makadzange is in network with 4 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.